AI Verdict
PBYI has stronger fundamentals based on our AI analysis.
PCB vs PBYI Fundamental Comparison
| Metric | PCB | PBYI |
|---|---|---|
| Revenue | $2.9M | $228.4M |
| Net Income | $37.5M | $31.1M |
| Net Margin | 1,291.9% | 13.6% |
| ROE | 9.6% | 23.9% |
| ROA | 1.1% | 14.4% |
| Current Ratio | N/A | 2.00x |
| Debt/Equity | 0.00x | 0.17x |
| EPS | $2.58 | $0.61 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
PCB vs PBYI: Frequently Asked Questions
Is PCB or PBYI a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), PBYI has stronger fundamentals. PCB is rated SELL (65% confidence) while PBYI is rated BUY (72% confidence). This is not investment advice.
How does PCB compare to PBYI fundamentally?
PCB BANCORP has ROE of 9.6% vs PUMA BIOTECHNOLOGY, INC.'s 23.9%. Net margins are 1,291.9% vs 13.6% respectively.
Which stock pays higher dividends, PCB or PBYI?
PCB has a dividend yield of N/A or no dividend while PBYI has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in PCB or PBYI for long term?
For long-term investing, consider that PCB has SELL rating with 65% confidence, while PBYI has BUY rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about PCB vs PBYI?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For PCB vs PBYI, the AI consensus favors PBYI based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.